Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous s... 著者: Amalia Domingo-González, Rafael Alonso Fernández, Ana Jiménez, Teresa De Soto Álvarez, Ana Lerma-Verdejo, Virginia Pradillo, Gonzalo Benzo Callejo, Jose Sánchez-Pina, Elena Landete, Alberto Velasco-Valdazo, Marina Menéndez-Cuevas, Mónica María López Riñón, Andrés Ramírez-López, María-Jesús Blanchard, Elham Askari

全文の入手